PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 143 filers reported holding PLIANT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,138 | -60.1% | 943 | -44.7% | 0.00% | – |
| Q1 2024 | $25,389 | +59.5% | 1,704 | +93.9% | 0.00% | – |
| Q4 2023 | $15,919 | -11.6% | 879 | -15.3% | 0.00% | – |
| Q3 2023 | $17,999 | -53.8% | 1,038 | -51.7% | 0.00% | – |
| Q2 2023 | $38,958 | +66.4% | 2,150 | +144.3% | 0.00% | – |
| Q1 2023 | $23,408 | +41.0% | 880 | +2.4% | 0.00% | – |
| Q4 2022 | $16,604 | -7.8% | 859 | 0.0% | 0.00% | – |
| Q3 2022 | $18,000 | +350.0% | 859 | +90.9% | 0.00% | – |
| Q2 2022 | $4,000 | +33.3% | 450 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -62.5% | 450 | -25.0% | 0.00% | – |
| Q4 2021 | $8,000 | -33.3% | 600 | -14.0% | 0.00% | – |
| Q3 2021 | $12,000 | -29.4% | 698 | +16.3% | 0.00% | – |
| Q2 2021 | $17,000 | -29.2% | 600 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $78,829,000 | 19.73% |
| CHI Advisors LLC | 2,569,479 | $34,688,000 | 11.51% |
| TRV GP IV, LLC | 2,132,867 | $28,794,000 | 8.28% |
| Bond & Devick Financial Network, Inc. | 120,160 | $1,622,000 | 1.22% |
| Redmile Group, LLC | 3,083,501 | $41,627,000 | 0.95% |
| Fernwood Investment Management, LLC | 174,260 | $2,353,000 | 0.77% |
| HARVARD MANAGEMENT CO INC | 562,379 | $7,592,000 | 0.71% |
| Grace Capital | 57,471 | $776,000 | 0.46% |
| Cormorant Asset Management, LP | 482,413 | $6,513,000 | 0.39% |
| First Light Asset Management, LLC | 386,896 | $5,223,000 | 0.37% |